These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

137 related items for PubMed ID: 6189902

  • 1. Human monoclonal antibodies to a genus-specific chlamydial antigen, produced by EBV-transformed B cells.
    Rosén A, Persson K, Klein G.
    J Immunol; 1983 Jun; 130(6):2899-902. PubMed ID: 6189902
    [Abstract] [Full Text] [Related]

  • 2. Monoclonal anti-parasite and anti-RBC antibodies produced by stable EBV-transformed B cell lines from malaria patients.
    Lundgren K, Wahlgren M, Troye-Blomberg M, Berzins K, Perlmann H, Perlmann P.
    J Immunol; 1983 Oct; 131(4):2000-3. PubMed ID: 6311902
    [Abstract] [Full Text] [Related]

  • 3. Establishment of specific antibody producing human lines by antigen preselection and Epstein-Barr virus (EBV)-transformation.
    Steinitz M, Koskimies S, Klein G, Mäkelä O.
    J Clin Lab Immunol; 1979 Apr; 2(1):1-7. PubMed ID: 95800
    [Abstract] [Full Text] [Related]

  • 4. Construction of human monoclonal antibodies against rabies NS-protein antigen by Epstein-Barr virus transformation.
    Gebauer W, Lindl T.
    Arzneimittelforschung; 1990 Jun; 40(6):718-22. PubMed ID: 2168706
    [Abstract] [Full Text] [Related]

  • 5. Renewal of EBV-hybridoma method: efficient generation of recombinant fully human neutralizing IgG antibodies specific for tetanus toxin by use of tetroma cells.
    Ainai A, Kawase T, Ida A, Maeda Y, Ohba H, Ikeda Y, Sato H, Takahashi M, Chiba J.
    Hum Antibodies; 2006 Jun; 15(4):139-54. PubMed ID: 17522436
    [Abstract] [Full Text] [Related]

  • 6. In vitro regulation of IgA subclass production. III. Selective transformation of IgA1 producing cells by Epstein-Barr virus.
    Conley ME, Chan MA, Sigal NH.
    J Immunol; 1987 Mar 01; 138(5):1403-7. PubMed ID: 3027178
    [Abstract] [Full Text] [Related]

  • 7. Efficient generation of human anti-cytomegalovirus IgG monoclonal antibodies from preselected antigen-specific B cells.
    Steenbakkers PG, Van Wezenbeek PM, van Zanten J, The TH.
    Hum Antibodies Hybridomas; 1993 Oct 01; 4(4):166-73. PubMed ID: 7504956
    [Abstract] [Full Text] [Related]

  • 8. Human lymphoblastoid cell line producing protective monoclonal IgG1, kappa anti-tetanus toxin.
    Tiebout RF, Stricker EA, Hagenaars R, Zeijlemaker WP.
    Eur J Immunol; 1984 May 01; 14(5):399-404. PubMed ID: 6327321
    [Abstract] [Full Text] [Related]

  • 9. Production of anti-tumor human monoclonal antibodies using different approaches.
    Liu H, Xu ZL, Wang Y, Yang L, Feng O, Li Y, Wang YM, Zhang GG.
    Hum Antibodies Hybridomas; 1993 Jan 01; 4(1):2-8. PubMed ID: 8381684
    [Abstract] [Full Text] [Related]

  • 10. Production of anti-endothelial cell antibodies by coculture of EBV-infected human B cells with endothelial cells.
    Delneste Y, Lassalle P, Jeannin P, Mannessier L, Dessaint JP, Joseph M, Tonnel AB.
    Cell Immunol; 1993 Aug 01; 150(1):15-26. PubMed ID: 7688268
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Human anti-pneumococci antibody produced by an Epstein Barr virus (EBV)-immortalized cell line.
    Steinitz M, Tamir S, Goldfarb A.
    J Immunol; 1984 Feb 01; 132(2):877-82. PubMed ID: 6317751
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. A human monoclonal antibody to cytomegalovirus (CMV).
    Emanuel D, Gold J, Colacino J, Lopez C, Hammerling U.
    J Immunol; 1984 Oct 01; 133(4):2202-5. PubMed ID: 6088634
    [Abstract] [Full Text] [Related]

  • 17. Human monoclonal anti-Plasmodium falciparum antibodies produced by stable EBV-transformed lymphocytes from patients with falciparum malaria.
    Khusmith S, Tharavanij S, Chongsa-Nguan M, Tapchaisri P, Sabchareon A, Bunnag D.
    Southeast Asian J Trop Med Public Health; 1987 Mar 01; 18(1):24-32. PubMed ID: 2821629
    [Abstract] [Full Text] [Related]

  • 18. In vitro generated human monoclonal trinitrophenyl-specific B cell lines. Evidence that human and murine anti-trinitrophenyl monoclonal antibodies cross-react with Escherichia coli beta-galactosidase.
    Golding B, Inghirami G, Peters E, Hoffman T, Balow JE, Tsokos GC.
    J Immunol; 1987 Dec 15; 139(12):4061-6. PubMed ID: 2826579
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. [Effect of specific treatment on the evolution of antibody titers against Chlamydia trachomatis measured by the immunofluorescence and complement fixation tests].
    Cañada JL, Urkiola MA, Cisterna JR.
    Enferm Infecc Microbiol Clin; 1990 Apr 15; 8(4):228-30. PubMed ID: 2090210
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.